All regulations
Nonrulemaking
FDA
Open for Comments
FDA-2026-P-4854
Requests that the FDA add Pharmacokinetic Parameters for estradiol be added to Table 2 in Section 12.3 of the full prescribing information inser for all doses of Premarin.
Documents
5
Comments
0
Key Dates
Comment Period OpensMay 5, 2026
Documents
| Type | Title | Status |
|---|---|---|
Supporting Material |
Keywords
CDER
Citizen Petition
Diamond Research Foundation
add Pharmacokinetic
Parameters for estradiol be added to
Table 2 in Section 12.3 of the full prescribing
information insert for all doses of Premarin
OPEN
Data from Regulations.gov